Change in C-reactive protein levels and FEV1 decline:: A longitudinal population-based study

被引:128
作者
Shaaban, Rafea
Kony, Sabine
Driss, Fathi
Leynaert, Benedicte
Soussan, David
Pin, Isabelle
Neukirch, Francoise
Zureik, Mahmoud
机构
[1] Fac Xavier Bichat, INSERM, Natl Inst Hlth & Med Res, Unit 700, F-75018 Paris, France
[2] Bichat Teaching Hosp, Paris, France
[3] Grenoble Teaching Hosp, Grenoble, France
关键词
C-reactive protein; epidemiology; forced expiratory volume in 1 s; longitudinal study;
D O I
10.1016/j.rmed.2006.03.027
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Reduced pulmonary function is an important predictor of cardiovascular morbidity and mortality. The mechanisms underlying this association are unknown but may involve systemic inflammation. We assessed the cross-sectional and longitudinal relationships between C-reactive protein (CRP) levels and forced expiratory volume in 1 s (FEV1) and its decline in the general population, over a period of 8.5 years. The analyzes were based on 531 subjects (mean age at baseline: 37 +/- 7 years, 50% women and 42% non-smokers), recruited at two French centers participating in the European Community Respiratory Health Survey. Lung function was expressed as a percentage of predicted FEV1. CRP was measured centrally, by means of a highly sensitive assay. In cross-sectional analysis, FEV1 as a % of predicted values was negatively associated with serum CRP concentration (P = 0.002). Multivariate adjustment did not alter these results (P = 0.002). In longitudinal analysis, annual FEV1 decline tended to increase from the lower to the upper tertile for baseline CRP concentration but the association was borderline significant (P = 0.14). Mean values of annual FEV, decline were 26 +/- 32, 31 +/- 32, and 34 +/- 32 ml/year for the lower, middle and upper tertiles of baseline CRP concentration, respectively, after adjusting for potential confounders (P = 0.09). Changes in CRP levels during follow-up were associated with annual FEV, decline. The mean annual FEV, declines in subjects with increasing CRP, in those with stable CRP and in those with decreasing CRP were 36 +/- 31, 30 +/- 31 and 24 +/- 31 ml/year, respectively (P < 0.001). These findings were not affected by adjustment for potential confounders (P = 0.002). In conclusion, increases in CRP levels over time were associated with a steeper FEV1 decline. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2112 / 2120
页数:9
相关论文
共 43 条
[2]
Chronic obstructive pulmonary disease: molecular and cellular mechanisms [J].
Barnes, PJ ;
Shapiro, SD ;
Pauwels, RA .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (04) :672-688
[3]
Need to test the arterial inflammation hypothesis [J].
Bhatt, DL ;
Topol, EJ .
CIRCULATION, 2002, 106 (01) :136-140
[4]
THE EUROPEAN-COMMUNITY-RESPIRATORY-HEALTH-SURVEY [J].
BURNEY, PGJ ;
LUCZYNSKA, C ;
CHINN, S ;
JARVIS, D ;
VERMEIRE, P ;
DAHL, R ;
NIELSEN, N ;
MAGNUSSEN, H ;
WICHMANN, H ;
PAPAGEORGIOU, N ;
ANTO, J ;
CAPELASTEGUI, A ;
CASTILLO, J ;
MALDONADO, J ;
MORATALLA, J ;
QUIROS, R ;
BOUSQUET, J ;
NEUKIRCH, F ;
PIN, I ;
TAYTARD, A ;
TECULESCU, D ;
PRICHARD, J ;
BUGIANI, M ;
DEMARCO, R ;
CASCIO, VL ;
RIJCKEN, B ;
AVILA, R ;
LOUREIRO, C ;
MARQUES, A ;
BURR, M ;
HALL, R ;
HARRISON, B ;
STARK, J ;
FLOREY, C ;
POPP, W ;
GISLASON, T ;
GULSVIK, A ;
ACKERMANNLIEBRICH, U ;
LINDHOLM, N ;
BOMAN, G ;
ROSENHALL, L ;
AITKHALED, N ;
ABRAMSON, M ;
MANFREDA, J ;
CHOWGULE, R ;
CRANE, J ;
STEPANOV, I ;
BUIST, S .
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (05) :954-960
[5]
Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults [J].
Celermajer, DS ;
Adams, MR ;
Clarkson, P ;
Robinson, J ;
McCredie, R ;
Donald, A ;
Deanfield, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :150-154
[6]
Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease [J].
Dahl, M ;
Tybjærg-Hansen, A ;
Vestbo, J ;
Lange, P ;
Nordestgaard, BG .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (06) :1008-1011
[7]
Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis [J].
Dwyer, JH ;
Allayee, H ;
Dwyer, KM ;
Fan, J ;
Wu, HY ;
Mar, R ;
Lusis, AJ ;
Mehrabian, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01) :29-37
[8]
Inflammatory response and body composition in chronic obstructive pulmonary disease [J].
Eid, AA ;
Ionescu, AA ;
Nixon, LS ;
Lewis-Jenkins, V ;
Matthews, SB ;
Griffiths, TL ;
Shale, DJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (08) :1414-1418
[9]
Lung function and cardiovascular risk -: Relationship with inflammation-sensitive plasma proteins [J].
Engström, G ;
Lind, P ;
Hedblad, B ;
Wollmer, P ;
Stavenow, L ;
Janzon, L ;
Lindgärde, F .
CIRCULATION, 2002, 106 (20) :2555-2560
[10]
INTERFERON BETA-2/B-CELL STIMULATORY FACTOR TYPE-2 SHARES IDENTITY WITH MONOCYTE-DERIVED HEPATOCYTE-STIMULATING FACTOR AND REGULATES THE MAJOR ACUTE PHASE PROTEIN RESPONSE IN LIVER-CELLS [J].
GAULDIE, J ;
RICHARDS, C ;
HARNISH, D ;
LANSDORP, P ;
BAUMANN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (20) :7251-7255